Buy Draxxin Tulathromycin for Cattle and Swine Online

Draxxin Injectable Solution is an antibiotic indicated for the treatment of bovine respiratory disease (BRD), infectious bovine keratoconjunctivitis (IBK) and foot rot in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine. Each ml contains 100 mg tulathromycin. The usual recommended dosage of Draxxin is 2.5 mg per kg (1.1 ml per 100 lbs) body weight, given in the neck. Do not administer more than 10 ml SQ per injection site in cattle. One dose provides up to 7-14 days BRD treatment and control. Do not administer more than 5 ml IM per injection site in swine. Not for use in female dairy cattle 20 months of age or older, or in calves to be processed for veal. Tulathromycin.

BRD – Draxxin Injectable Solution is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis; and for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis. IBK – Draxxin Injectable Solution is indicated for the treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis.

Foot Rot – Draxxin Injectable Solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii.

Buy Draxxin (Tulathromycin) Injectable Solution Online: The Definitive Veterinary Guide to Triamilide Macrolide Pharmacology, Rapid Lung Tissue Targeting, and Single-Dose Respiratory Control in Cattle and Swine

Managing outbreaks of Bovine Respiratory Disease (BRD) and Swine Respiratory Disease (SRD) is one of the most critical challenges in commercial livestock production and feedlot management. Environmental stressors—such as long-distance shipping, sudden weather changes, weaning, and commingling—weaken the animal’s upper respiratory defenses. This physiological stress opens the door for opportunistic bacterial pathogens to colonize the deep lung tissue, triggering severe bronchial inflammation, fluid buildup, high fever, and structural lung damage.

Left untreated, respiratory disease spreads rapidly through pens, causing high mortality rates, reduced feed efficiency, and permanent lung scarring that impacts lifetime market weight.

Traditional short-acting antibiotics often require daily pen gathers and repeated handling injections. This frequent intervention increases stress on sick animals, raises labor costs, and increases the risk of injection-site lesions.

To achieve rapid therapeutic drug levels in the lungs while minimizing animal handling, livestock veterinarians rely on long-acting macrolide antimicrobials. Draxxin Injectable Solution (manufactured by Zoetis) is a premier, single-dose injectable antibiotic approved for treating and controlling BRD, SRD, pinkeye, and foot rot. Powered by Tulathromycin—a unique subclass of macrolide known as a triamilide—Draxxin rapidly concentrates in pulmonary tissues, delivering sustained therapeutic activity for up to 14 days from a single subcutaneous or intramuscular injection.

This comprehensive clinical manual covers the unique triamilide pharmacology, tissue distribution mechanics, target species indications, and precise administration protocols for Draxxin.

Triamilide Pharmacology & Advanced Lung Tissue Targeting

Draxxin delivers a highly targeted, long-acting antibacterial response designed specifically for pulmonary tissue architecture:

                          [Draxxin 100mg/ml Administered]
                                         |
                      [Rapid Subcutaneous / Intramuscular Entry]
                                         |
                      [High Affinity for Neutrophils & Macrophages]
                                         |
               -------------------------------------------------
              |                                                 |
      [TISSUE DISTRIBUTION]                           [BACTERIAL PROTEIN BLOCK]
     (Rapid Concentration)                           (50S Ribosomal Binding)
              |                                                 |
              v                                                 v
   [Concentrates directly in Lungs]                [Inhibits Translocation Steps]
   (Lung Levels Exceed Plasma Concentrations)      (Stops Bacterial Protein Synthesis)
              |                                                 |
              v                                                 v
   [Sustained Activity for up to 14 Days]           [Halts Pathogen Replication]
              |                                                 |
               =========================> <=====================
                                         |
                                         v
                    [Rapid Resolution of Clinical Fever & Coughing]
                                         |
                    [Single-Dose Cure & Long-Term Herd Metaphylaxis]

Triamilide Chemistry and Ribosomal Inhibition

Tulathromycin ($100\text{mg/mL}$) is a semi-synthetic macrolide antimicrobial that features three amino groups within its chemical structure, classifying it as a triamilide. This distinct structure allows the drug to penetrate bacterial cell walls easily. Tulathromycin binds to the 50S subunit of the bacterial ribosome, blocking essential protein synthesis and stopping bacterial growth and replication.

Targeted Pulmonary Accumulation

A key clinical feature of Draxxin is its targeted tissue distribution. Following a single injection, tulathromycin is rapidly absorbed into the bloodstream and actively taken up by immune cells (macrophages and neutrophils). These immune cells transport the medication directly to the site of pulmonary infection:

• High Tissue Concentrations: Drug concentrations in lung tissue quickly exceed plasma levels and remain elevated well above the Minimum Inhibitory Concentration (MIC90​) for key respiratory pathogens.

• Sustained Coverage: A single dose provides up to 10 to 14 days of active protection in lung tissue, eliminating the need for daily booster injections.

Broad-Spectrum Pathogen Coverage

Draxxin demonstrates high efficacy against the primary bacterial causes of livestock disease:

• Bovine Pathogens: Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, Mycoplasma bovis, Moraxella bovis (Pinkeye), and Fusobacterium necrophorum (Foot rot).

• Swine Pathogens: Actinobacillus pleuropneumoniae, Pasteurella multocida, Mycoplasma hyopneumoniae, Haemophilus parasuis, and Bordetella bronchiseptica.

Core Livestock Clinical Indications

Draxxin 100mg/ml is a foundational therapeutic tool utilized across cattle ranches, feedlots, and swine operations:

• Bovine Respiratory Disease (BRD) Treatment & Metaphylaxis: Treats active BRD outbreaks and serves as a first-line preventative (metaphylactic) treatment for high-risk feeder calves upon arrival.

• Infectious Bovine Keratoconjunctivitis (IBK / Pinkeye): Rapidly clears stubborn ocular infections caused by Moraxella bovis, reducing pain and preventing corneal scarring.

• Bovine Interdigital Necrobacillosis (Foot Rot): Resolves acute foot rot infections caused by Fusobacterium necrophorum, restoring normal weight-bearing mobility.

• Swine Respiratory Disease (SRD) Control: Treats and controls group outbreaks of SRD in nursery and finishing pigs, maintaining herd growth rates.

Recommended Administration and Dosing Protocols

To guarantee proper therapeutic outcomes and preserve food safety standards, Draxxin must be administered following strict weight-based parameters.

Species Dosage and Administration Reference Table

The table below outlines standard clinical dosing parameters for Draxxin Injectable Solution ($100\text{mg/mL}$):

Clinical Safety, Food Safety Regulations, and Storage

• Dairy Cattle Restrictions: Do not use Draxxin in female dairy cattle 20 months of age or older, as safety and milk residue parameters have not been established for lactating dairy cows. Do not use in calves to be processed for veal.

• Mandatory Slaughter Withdrawal Periods:

  • Cattle: Must not be slaughtered for human consumption within 18 days of the last treatment.

  • Swine: Must not be slaughtered for human consumption within 5 days of the last treatment.

• Injection Site Limits: Always adhere to volume restrictions per site ($10\text{mL}$ in cattle, $2.5\text{mL}$ in swine) to prevent localized tissue irritation and ensure uniform absorption.

• Storage Parameters: Store between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C. Protect from direct sunlight. Use within 45 days of first puncture for multi-dose vials.

Frequently Asked Questions (FAQ)

What makes Draxxin different from conventional livestock antibiotics?

Draxxin uses Tulathromycin, a triamilide macrolide that rapidly accumulates in lung tissue and immune cells. A single injection provides therapeutic drug levels in the lungs for up to 14 days, whereas conventional options often require daily injections.

Can Draxxin be given intravenously (IV)?

No. Draxxin must be administered Subcutaneously (SQ) in cattle and Intramuscularly (IM) in swine. Intravenous administration is contraindicated and can lead to adverse cardiovascular reactions.

How quickly does Draxxin start working after injection?

Tulathromycin is absorbed rapidly from the injection site. Peak plasma concentrations occur within 1 to 3 hours, and the drug rapidly concentrates in lung tissue to begin fighting bacterial pathogens.

Where can I buy genuine Draxxin 100mg/ml online?

You can safely purchase authentic, factory-sealed Draxxin Injectable Solution online through Vet Pharma Med. We manage our full inventory under strict environmental controls to guarantee absolute product integrity and full therapeutic potency.

Secure Premium Sourcing from Vet Pharma Med

At Vet Pharma Med, we understand that maintaining livestock herd health requires reliable, high-standard pharmaceuticals. Every container of Draxxin (Tulathromycin) 100mg/ml Injectable Solution is sourced through authorized distribution networks, stored in our climate-controlled facility, and shipped securely to protect product quality.